Skip to main content

stock

CLDI · Calidi Biotherapeutics, Inc.

What Calidi Biotherapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live CLDI price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on CLDI.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
2,584,184 as of 2026-08-10 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-557.7%
ROA
-242.5%

Health

Current ratio
1.7x
Debt/equity
0.2x

Deep value

NCAV
$1.36M
NCAV per share
$0.53
Price/NCAV
Locked
NNWC
$219,000
NNWC per share
$0.08
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$4.15M-$4.16M
10-Q filed 2026-08-13
2026-03-31——Gross profit: unreported by this company.-$4.19M-$4.11M
10-Q filed 2026-05-14
2025-12-31——Gross profit: unreported by this company.-$4.47M-$4.06M
10-K filed 2026-03-27
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——Gross profit: unreported by this company.-$5.05M-$5.15M
10-Q filed 2025-11-13
2025-06-30——Gross profit: unreported by this company.-$5.66M-$5.71M
10-Q filed 2026-08-13
2025-03-31——Gross profit: unreported by this company.-$5.06M-$4.99M
10-Q filed 2026-05-14
2024-12-31——Gross profit: unreported by this company.-$4.03M-$4.10M
10-K filed 2026-03-27
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——Gross profit: unreported by this company.-$5.23M-$5.05M
10-Q filed 2025-11-13
Assets
$7.20M
Equity
$3.13M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$20.24M-$19.91M—
2024-12-31—-$21.78M-$22.14M—
2023-12-31—-$28.99M-$29.22M—
2022-12-31$45,000-$23.13M-$25.43M—

Company filings

3 offering filings in 12 months · since Thu Sep 17

events

  • Listing standard notice, Other event

    Listing standard noticeOther event
    Sep 258-K
  • Material agreement, Other event

    Material agreementOther event
    Sep 228-K
  • Results, Regulation FD disclosure

    ResultsRegulation FD disclosure
    Aug 138-K
  • Shareholder rights changed, Bylaws or fiscal year change

    Shareholder rights changedBylaws or fiscal year change
    Jul 318-K
  • Material agreement, Agreement ended, New debt

    Material agreementAgreement endedNew debt
    Jul 168-K
  • Executive or director change, Regulation FD disclosure, Other event

    Executive or director changeRegulation FD disclosureOther event
    Jun 238-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named CLDI, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about CLDI.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about CLDI.

nakagai

Signals on CLDI come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the CLDI board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Calidi Biotherapeutics, Inc. (CLDI): SEC filings, financials and insider trades · Nakagai